SYNLOGIC, INC. Payments to Acquire Marketable Securities
SYNLOGIC, INC. (SYBX) reported Payments to Acquire Marketable Securities of $79.79 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2016-11-10
- SYNLOGIC, INC. payments to acquire marketable securities for the quarter ending 2016-09-30 was $28.94M.
- SYNLOGIC, INC. payments to acquire marketable securities for the quarter ending 2016-06-30 was $23.13M.
- SYNLOGIC, INC. payments to acquire marketable securities for the quarter ending 2016-03-31 was $27.72M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month |
|---|---|---|---|
| 2016-09-30 | $28.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $52.06M derived: sum of 2 quarters · filed 2016-11-10 | $79.79M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $23.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $50.85M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $27.72M 10-Q · filed 2016-05-12 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |